Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Recruiting · NCT06650488 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia | Staphylococcus Aureus Bloodstream Infection; Staphylococcus Aureus Endocarditis; Staphylococcus Aureus Septicemia | Recruiting | Phase 4 | 2026-09-24 | NCT06650488 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Todd C. Lee MD MPH FIDSA | 4 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital) | Montreal | Canada | 3 |
| NL and Labrador Health Services- Health Sciences Centre | St. John's | Canada | 1 |
| NL and Labrador Health Services- St. Clare's Mercy Hospital | St. John's | Canada | 2 |